{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-24-036279","form_type":"8-K","ticker":"INSM","cik":"0001104506","company_name":"INSMED Inc","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.185861+00:00","generated_at":"2026-05-31T10:40:53.934739+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Insmed Q2 2024 revenue $90.3M (+17% YoY); net loss $300.6M; guides FY $340-360M","bullets":["ARIKAYCE global revenue $90.3M in Q2 2024, up 17% YoY; U.S. $63.8M, Japan $21.1M, Europe $5.4M.","Net loss $300.6M ($1.94/sh) vs $244.8M loss ($1.78/sh) in Q2 2023; includes $103.7M non-cash fair value charge.","Reiterated FY2024 ARIKAYCE revenue guidance $340M-$360M, representing ~15% YoY growth at midpoint.","Completed public offering of 14.5M shares; net proceeds $713.2M. Redeemed $225M convertible notes due 2025.","Plan to file NDA for brensocatib in bronchiectasis in Q4 2024; Phase 3 ASPEN met primary endpoint with statistical significance."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-24-036279","json":"https://secwatch.observer/filing/0001140361-24-036279.json","markdown":"https://secwatch.observer/filing/0001140361-24-036279.md","text":"https://secwatch.observer/filing/0001140361-24-036279.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1104506/000114036124036279/0001140361-24-036279-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1104506/000114036124036279/ef20033779_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:40:53.934739+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}